Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Crohn's Disease

In brief

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in Crohn's disease (CD).

Key facts

Study ID
NCT02914600
Run by
Lakefront Biotherapeutics NV
People needed
1188
Starts
2017-03-17
Expected to finish
2023-08-01
Last updated by the study team
2024-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.